Home Biosimilar Antibodies Immunology & Inflammation Immunology & Inflammation related antibody Zalifrelimab (Anti-CTLA-4 / CD152) For research use only.
Not for use in humans.

Zalifrelimab (Anti-CTLA-4 / CD152)

Synonyms: AGEN1884

Zalifrelimab (Anti-CTLA-4 / CD152) is a recombinant human monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with immune checkpoint inhibitory and antineoplastic activities. MW: 144.48 KD.

Zalifrelimab (Anti-CTLA-4 / CD152)

Purity & Quality Control

≥99

Choose Selective Immunology & Inflammation related Inhibitors

Biological Activity

Description Zalifrelimab (Anti-CTLA-4 / CD152) is a recombinant human monoclonal antibody directed against the human T-cell receptor cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), with immune checkpoint inhibitory and antineoplastic activities. MW: 144.48 KD.

Product Details

CAS No. 2148321-69-9
Molecular Weight 144.48
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Zalifrelimab (Anti-CTLA-4 / CD152) | Zalifrelimab (Anti-CTLA-4 / CD152) supplier | purchase Zalifrelimab (Anti-CTLA-4 / CD152) | Zalifrelimab (Anti-CTLA-4 / CD152) cost | Zalifrelimab (Anti-CTLA-4 / CD152) manufacturer | order Zalifrelimab (Anti-CTLA-4 / CD152) | Zalifrelimab (Anti-CTLA-4 / CD152) distributor